Pharma News: April 2004

April 1	FDA approves Vioxx for acute treatment of migraine in adults
April 5	FDA approves Cardizem LA for treatment of angina
April 5	BAY 43-9006 receives fast track designation for metastatic kidney cancer review
April 7	Approval of Ribasphere 200mg for treatment of chronic hepatitis C
April 8	Aromatase inhibitors may replace tamoxifen
April 12	New report confirms aspirin's cardioprotective benefits far outweigh risks in wide array of patients
April 12	Newer antipsychotic drugs appear to stem violent behavior in schizophrenia sufferers
April 12	FDA approves new formulation for filterless administration of Protonix I.V.
April 12	Approval for new dosage strength of Zantac Efferdose Tablets
April 13	WHI study finds no heart disease benefit, increased stroke risk with estrogen alone (Premarin)
April 13	Wyeth: Latest WHI data links Premarin to reduced incidence of fracture and fewer cases of breast cancer
April 13	FDA partners with states to warn consumers that "looks can be deceiving"
April 13	Repackager of foreign drugs agrees to comply with FDA's rules
April 14	Tentative approval for generic anti-cancer compound carboplatin
April 15	Aventis announces FDA approval of Nasacort HFA Nasal Aerosol
April 16	Ziagen receives traditional approval status from FDA
April 21	FDA approves Apokyn for acute treatment of immobility episodes in Parkinson's patients
April 22	FDA approves Advair Diskus 100/50 mcg for children four to eleven
April 23	FDA approves Hylaform gel acid-based dermal filler for correction of facial wrinkles
April 26	FDA approves supplemental list of susceptible pathogens for Vigamox ophthalmic solution
April 26	FDA approves new indication for Hectorol in pre-dialysis chronic kidney disease
April 28	FDA gives pancreatic extract manufacturers up to 4 years to obtain NDA approvals
April 28	Prodose Adaptive Aerosol Delivery system receives FDA approval
April 28	FDA approves chewable version of Zyrtec allergy medicine for children
April 28	Andrx receives FDA approval for Fortamet; also plans to market Altocor under a new name
April 28	Teva announces approval of Fludarabine Phosphate InjectionFDA gives pancreatic extract manufacturers up to 4 years to obtain NDA approvals
April 29	Teva announces approval of Fludarabine Phosphate Injection
April 30	FDA approves Enbrel -- new biologic drug for psoriasis

2008: Jan | Feb | Mar | Apr | May
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

Pharma News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals

	A to Z Drug List	Drugs by Condition	Pill Identifier	Drug Interactions Checker	Medical Encyclopedia	Medical Dictionary	Pharmaceutical News & Articles	Community Forums
Welcome Guest\|Register or Sign In My Viewing History \| My Drug List \| My Interactions Lists \| Member Offers

Pharma News Archive

Pharma News: April 2004

Pharma News Archive

More News Resources